Elemer Piros
Stock Analyst at LUCID CAPITAL MARKETS
(1.26)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BTAI BioXcel Therapeutics | Reiterates: Buy | 66 66 | 6.36 | 937.74% | 2 | Jul 15, 2025 | |
FBLG FibroBiologics | Initiates Coverage On: Buy | 12 | 0.55 | 2081.82% | 1 | Dec 12, 2024 | |
THAR Tharimmune | Initiates Coverage On: Buy | 17 | 1.17 | 1352.99% | 1 | Dec 6, 2024 | |
QNCX Quince Therapeutics | Initiates Coverage On: Buy | 11 | 1.58 | 596.2% | 1 | Oct 29, 2024 | |
MNPR Monopar Therapeutics | Initiates Coverage On: Buy | 50 | 31.34 | 59.54% | 6 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | 1.42 | 1097.18% | 1 | Sep 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | n/a | n/a | 1 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 107 107 | 2.25 | 4655.56% | 1 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 14 14 | 0.85 | 1547.06% | 1 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 67 67 | 2.82 | 2275.89% | 1 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 43 | 3.06 | 1305.23% | 1 | Jun 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 6.09 | 195.57% | 7 | Jun 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 8 | 1.15 | 552.17% | 3 | Sep 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 3.96 | 278.79% | 8 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 21 | 9.98 | 110.42% | 8 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 | 4.33 | 777.6% | 9 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 | 0.68 | 5782.35% | 2 | Jul 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 50 | 4.01 | 1146.88% | 5 | Jun 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 114 | 7.28 | 1465.93% | 3 | Jun 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 200 | 3.79 | 5177.04% | 6 | Jun 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 23 | 3.41 | 574.49% | 2 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 33 | 11.78 | 180.14% | 3 | Mar 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 | 1.12 | 882.14% | 2 | Feb 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 40 | 23.87 | 67.57% | 7 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 40 | n/a | n/a | 3 | Jan 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 37 | 1.43 | 2487.41% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 38 32 | 4.6 | 595.65% | 2 | Jun 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 128 124 | n/a | n/a | 7 | May 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | n/a | n/a | 1 | Apr 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 77 | 11.39 | 576.03% | 2 | Dec 23, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 1.86 | 3663.44% | 1 | Oct 12, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 240 | n/a | n/a | 1 | Sep 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Sep 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 21 24 | 1.3 | 1746.15% | 4 | May 28, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 225 75 | n/a | n/a | 2 | May 12, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 50 | 17.2 | 190.7% | 5 | Nov 19, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 33 | 5.24 | 529.77% | 2 | Oct 22, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 191 186 | 19 | 878.95% | 4 | Aug 8, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 3 | Jul 11, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 26 | 4.13 | 529.54% | 3 | May 6, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 115 | n/a | n/a | 3 | Feb 25, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 21 | n/a | n/a | 1 | Nov 7, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 28 | 137.58 | -79.65% | 1 | Sep 11, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 17 | 2 | 750% | 2 | Aug 9, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 70 65 | 11.1 | 485.59% | 2 | Jun 13, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 525 850 | 6.28 | 13435.03% | 1 | Oct 12, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 204 84 | n/a | n/a | 2 | Sep 22, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | n/a | n/a | 1 | Jul 20, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 35 21 | 12.56 | 67.2% | 2 | Jul 12, 2017 |